Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
@article{Knudsen2016DifferentHV, title={Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens}, author={N. P. Knudsen and A. Olsen and C. Buonsanti and Frank Follmann and Y. Zhang and R. Coler and Christopher B Fox and Andreas Meinke and Ugo D´Oro and D. Casini and A. Bonci and R. Billeskov and E. De Gregorio and R. Rappuoli and A. Harandi and P. Andersen and E. Agger}, journal={Scientific Reports}, year={2016}, volume={6} }
The majority of vaccine candidates in clinical development are highly purified proteins and peptides relying on adjuvants to enhance and/or direct immune responses. Despite the acknowledged need for novel adjuvants, there are still very few adjuvants in licensed human vaccines. A vast number of adjuvants have been tested pre-clinically using different experimental conditions, rendering it impossible to directly compare their activity. We performed a head-to-head comparison of five different… CONTINUE READING
Figures, Tables, and Topics from this paper
Paper Mentions
128 Citations
Influenza NG-34 T cell conserved epitope adjuvanted with CAF01 as a possible influenza vaccine candidate
- Biology, Medicine
- Veterinary Research
- 2020
- 2
- Highly Influenced
Immunology and efficacy of MF59-adjuvanted vaccines
- Medicine
- Human vaccines & immunotherapeutics
- 2018
- 14
Modulation of Primary Immune Response by Different Vaccine Adjuvants
- Biology, Medicine
- Front. Immunol.
- 2016
- 37
- PDF
Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines.
- Biology, Medicine
- Biotechnology advances
- 2017
- 41
Rational Design and In Vivo Characterization of Vaccine Adjuvants.
- Biology, Medicine
- ILAR journal
- 2019
- 1
- PDF
Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization
- Medicine
- Frontiers in Immunology
- 2020
- 1
- PDF
B cell targeting by molecular adjuvants for enhanced immunogenicity
- Biology, Medicine
- Expert review of vaccines
- 2020
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
- Biology, Medicine
- Front. Immunol.
- 2017
- 29
- PDF
Adjuvants as Delivery Systems in Antigen-Specific Immunotherapies.
- Chemistry, Medicine
- Journal of pharmaceutical sciences
- 2019
Role of Metallic Nanoparticles in Vaccinology: Implications for Infectious Disease Vaccine Development
- Medicine, Biology
- Front. Immunol.
- 2017
- 38
- PDF
References
SHOWING 1-10 OF 77 REFERENCES
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
- Biology, Medicine
- PloS one
- 2010
- 124
- PDF
CAF01 Potentiates Immune Responses and Efficacy of an Inactivated Influenza Vaccine in Ferrets
- Biology, Medicine
- PloS one
- 2011
- 26
- PDF
Vaccine adjuvants: scientific challenges and strategic initiatives
- Medicine
- Expert review of vaccines
- 2009
- 84
MF59 and Pam3CSK4 Boost Adaptive Responses to Influenza Subunit Vaccine through an IFN Type I-Independent Mechanism of Action
- Biology, Medicine
- The Journal of Immunology
- 2012
- 90
- PDF
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.
- Medicine
- Vaccine
- 2014
- 140
Vaccines with MF59 Adjuvant Expand the Antibody Repertoire to Target Protective Sites of Pandemic Avian H5N1 Influenza Virus
- Biology, Medicine
- Science Translational Medicine
- 2010
- 221
Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age
- Medicine
- The Pediatric infectious disease journal
- 2015
- 24